Clinical trial
Atorvastatin in Myeloma
NCT00164086 · Bayside Health, Other · Unknown status
Key facts
| NCT number | NCT00164086 |
|---|---|
| Title | Atorvastatin in Myeloma |
| Lead sponsor | Bayside Health, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Myeloma |
| Intervention type | Drug |
| Interventions | atorvastatin |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 11, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: